CJC-1295 No DAC Research Reference

Catalog classification, reference sizes, lab math links, and source-backed data. Educational use only — not medical advice.

Researched for: growth hormone signaling research

Growth Signal Research peptide Lyophilized verified

Also known as: CJC1295 no DAC, Mod GRF 1-29

Open in Calculator ← Compound Index All Tools

Quick Facts

Reference Sizes

2 mg, 5 mg, 10 mg

Calculator

Preset available

Storage

Lyophilized: store at -20 deg C. After reconstitution: refrigerate 2-8 deg C; verify beyond-use timing against source COA.

Solubility

Supplier and salt-form dependent; no approved formulation or universal reconstitution standard exists

Catalog Description

Products called CJC-1295 No DAC are generally modified GRF(1-29) rather than the albumin-binding CJC-1295 DAC studied in healthy adults. The approximately 30-minute half-life and community microgram protocols are not supported by direct human PK studies of the marketed material. The naming ambiguity should be explicit in the catalog.

Catalog descriptions reflect research context only. Not a medical claim or treatment recommendation.

Research Profile

Half-Life

Often reported as about 30 minutes by vendors but not established in a direct human PK study of the marketed no-DAC material

Onset

No validated human onset is established

Administration Routes (Research)

SC (community and gray-market practice only)

Reported Research Effects

GHRH-receptor agonism inferred from peptide design
Transient growth-hormone signaling in preclinical or extrapolated models
No direct controlled human trial for the gray-market no-DAC product

Reported Research Side Effects

Human safety is not established
Class-based concerns include flushing and cardiovascular effects
Immunogenicity and impurity risk for unapproved material

Data source: FDA regulatory review, GHRH pharmacology, and current vendor market checks

Reflects preclinical/research literature context only. Not a medical claim, dosing instruction, or treatment recommendation.

Research Protocols Reported in the Literature

No validated human dosing protocol has been published for material marketed as CJC-1295 No DAC [SC; Not established; Not established]Source: FDA compounding review and literature gap

Research Interactions

Flagged Avoid / Caution Combinations (Research)

Other growth-hormone secretagogues or exogenous growth hormone without monitored research oversight

Reflects patterns reported in research/community literature only. Not a safety guarantee, medical advice, or interaction warning for human use.

Research Notes

A human decision is needed on renaming this record to Modified GRF(1-29). Current vendors sell 2 mg 5 mg and 10 mg lyophilized vials; community schedules remain anecdotal and are not presented as clinical protocols.

Supplementary research context only. Not medical advice or a treatment recommendation.

Sources

FDA list of bulk substances presenting potential safety risks — U.S. Food and Drug Administration
https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks

Metabolic clearance of human pancreatic GHRF — PubMed (NIH)
https://pubmed.ncbi.nlm.nih.gov/6425363/

Suggest a community source

Found a relevant Reddit or forum thread about this compound? Suggest it below. Every suggestion is reviewed by an editor before it appears -- nothing is published automatically.

Related Research Tools

Reconstitution CalculatorConcentration, draw volume, per-unit amounts Unit Convertermg, mcg, mL, units conversion Compound CompareSide-by-side comparison tool Cost CalculatorCost per mg, mcg, per-draw

Research Use Only. All content is for educational and research reference only. Not medical advice, a treatment recommendation, or guidance on human use. Compounds are not FDA-approved drugs unless specifically noted.